Business Transfer Agreement Sample Contracts

Hongli Clean Energy Technologies Corp. – Translation of Assets and Business Transfer Agreement (May 23rd, 2016)

Transferor ("Party A"): Henan Pingdingshan Hongli Coal and Coking Co., Ltd. ("Hongli") and its branch Baofeng Coking Factory of Henan Pingdingshan Hongli Coal and Coking Co., Ltd. ("Baofeng Coking") Transferee (" Party B"): Pingdingshan Hongfeng Coal Processing and Coking Factory ("Hongfeng")

Xunlei Ltd – English Summary* of Assets and Business Transfer Agreement by and Between Beijing Kingsoft Cloud Network Technology Co., Ltd. Zhuhai Kingsoft Cloud Science and Technology Co., Ltd. Beijing Kingsoft Cloud Science and Technology Co., Ltd. And Shenzhen Xunlei Networking Technologies Co., Ltd. September 2, 2014 (April 20th, 2015)

This Assets and Business Transfer Agreement (This Agreement) is signed by the following parties on September 2, 2014 (Date of Signing) in Beijing, the Peoples Republic of China (China):

Majesco – Business Transfer Agreement Between Mastek (Uk) Limited and Majesco Uk Limited (April 1st, 2015)

MASTEK (UK) LIMITED, a company incorporated in England and Wales under the registration number 02731277 and having its registered office at Pennant House, 2 Napier Court, Napier Road, Reading. RG1 8BW (hereinafter referred to as "Vendor", which expression shall unless repugnant to the context or meaning thereof include their successors) of the One Part;

Tower Semiconductor Ltd. – Business Transfer Agreement (November 17th, 2014)
Article I DEFINITIONS 1 Section 1.01. Certain Defined Terms 1 Article II PURCHASE AND SALE 2 Section 2.01. Purchase and Sale of the Shares 2 Section 2.02. Purchase and Sale of Assets 2 Section 2.03. Assignment of Contracts and Rights 9 Section 2.04. Closing 9 Section 2.05. Purchase Price 10 Section 2.06. Closing Adjustment 10 Section 2.07. Closing Deliveries by GE 11 Section 2.08. Closing Deliveries by the Buyer 12 Section 2.09. Post-Closing Statements 13 Section 2.10. Reconciliation of Post-Closing Statements 13 Section 2.11. Post- Closing Working Capital Adjustment 14 Section 2.12. Payments A (November 5th, 2013)

This PURCHASE AGREEMENT, dated as of November 5, 2013, is made between GENERAL ELECTRIC COMPANY, a New York corporation (GE), and CLARCOR INC., a Delaware corporation (the Buyer).

Lotus Pharmaceutical – Business Transfer Agreement (January 9th, 2012)

After friendly discussion and negotiation between both parties, and with the goal of equality and mutual benefit, Liang Fang Pharmaceutical Co., Ltd. (Party A) and Meng Xin Vegetable Product Co., Ltd. (Party B) reach an agreement regarding the transfer of assets and liabilities of Liang Fang Inner Mongolia branch company, Beijing Feng Tai Drug Store, Beijing Yong An Zhong Sheng Drug Store, and Beijing He Ping Li Drug Store, which are wholly owned by Party A. Detail arrangements are as follows:

Akorn, Inc. – Business Transfer Agreement by and Among Kilitch Drugs (India) Limited and Akorn India Private Limited and Promoters Listed in Schedule 1 and Akorn, Inc. (October 6th, 2011)

Until the Closing, the Seller shall give prompt written notice to the Purchaser of (a) the occurrence, or non-occurrence, of any event, the occurrence or non-occurrence of which would reasonably be expected to cause any representation or warranty of the Seller contained in this Agreement to be untrue or inaccurate, in each case at any time from and after the Effective Date until the Closing; (b) any failure to comply with or satisfy any covenant or agreement to be complied with or satisfied by the Seller under this Agreement; and (c) the failure of any condition precedent to the Purchaser's obligations under this Agreement. No notification pursuant to this Clause 6.4 shall be deemed to amend or supplement the Seller Disclosure Schedule, prevent or cure any misrepresentation, breach of warranty or breach of covenant, or limit or otherwise affect any rights or remedies available to the Purchaser.

Amendment No. 1 to Business Transfer Agreement (September 8th, 2010)

This Amendment No. 1 to Business Transfer Agreement (this Amendment), made as of September 8, 2010, is entered into by and among Abbott Healthcare Private Limited, a private limited company formed under the Laws of India and having its registered office at 4, Corporate Park, Sion Trombay Road, Mumbai-400 071, Maharashtra, India (Purchaser), and solely for the purposes of Section 7.18 of the BTA (as defined herein), Abbott Laboratories, an Illinois corporation and the indirect ultimate corporate parent of Purchaser (the Guarantor), on the one hand, and Piramal Healthcare Limited, a public limited company formed under the Laws of India and having its registered office at Piramal Tower, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400 013, Maharashtra, India and listed on the Bombay and National stock exchanges (Seller), and, solely for purposes of Sections 7.5(c), 7.6, 10.6 and 11.12 of the BTA, the shareholders of Seller listed on Exhibit A of the BTA who, as of December 31, 2009, held, in

Trestle Holdings – SMART LEAD ENTERPRISES LIMITED and VIVA RED COMPANY LIMITED Business Transfer Agreement (July 13th, 2010)
BUSINESS TRANSFER AGREEMENT by Piramal Healthcare Limited (Seller) and Abbott Healthcare Private Limited (Purchaser) Dated May 21, 2010 (May 21st, 2010)

This Business Transfer Agreement (this Agreement) is made as of May 21, 2010, by and among Abbott Healthcare Private Limited, a private limited company formed under the Laws of India and having its registered office at 4, Corporate Park, Sion Trombay Road, Mumbai-400 071, Maharashtra, India (Purchaser), and solely for the purposes of Section 7.18, Abbott Laboratories, an Illinois corporation and the indirect ultimate corporate parent of Purchaser (the Guarantor), on the one hand, and Piramal Healthcare Limited, a public limited company formed under the Laws of India and having its registered office at Piramal Tower, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400 013, Maharashtra, India and listed on the Bombay and National stock exchanges (Seller), and solely for purposes of Sections 7.5(c), 7.6, 10.6 and 11.12 the shareholders of Seller listed on Exhibit A who, as of December 31, 2009, held, in the aggregate, 103,232,499 shares of Seller, which represented approximately 49.39% of the i

AMENDMENT NO. 1 to BUSINESS TRANSFER AGREEMENT (April 1st, 2010)

This Amendment No. 1 (this Amendment) is made and entered into as of March 30, 2010 by and between Orchid Chemicals & Pharmaceuticals Ltd., a company incorporated under the Act (Orchid), and Hospira Healthcare India Private Limited, a company incorporated under the Act (Hospira), for the purpose of amending that certain Business Transfer Agreement, dated as of December 15, 2009, by and among Orchid, Mr. K. Raghavendra Rao and Hospira (the Agreement). Capitalized terms not defined herein shall have the meanings given to them in the Agreement.

China Time Share Media Co. Ltd – Sichuan Time Share Advertising & Communication Co., Ltd. Chengdu Zhengyang Advertising Co., Ltd. And Min Yang, Fengying Wu, Zhixun Dai Employees and Business Transfer Agreement May 8, 2007 (September 9th, 2008)

This Employees and Business Transfer Agreement (hereinafter Agreement ) is entered into among the following parties on May 8, 2007:

Arkansas Aerospace Inc – Asset and Business Transfer Agreement (December 4th, 2007)
Business Transfer Agreement Between (April 2nd, 2007)

(1) Lumberg Automation GmbH (hereinafter referred to as SELLER I); (2) LuS Lumberg GmbH & Cie KG (hereinafter referred to as SELLER II); (3) Lumberg Ltd. (hereinafter referred to as SELLER III); (4) Lumberg S.a.r.l. (hereinafter referred to as SELLER IV); (5) Lumberg Asia Pacific Pte. Ltd. (hereinafter referred to as SELLER V); (6) Lumberg, Inc. (hereinafter referred to as SELLER VI);

Infinity Pharmaceuticals – BUSINESS TRANSFER AGREEMENT Between Biofrontera Discovery GmbH Waldhofer Str. 104, D-69127 Heidelberg, Germany (Seller) and EQUITY Neunte Vermogensverwaltungs GmbH (Kunftig: Discovery Partners International GmbH) Kaiser-Joseph-Strasse 284, D-79098 Freiburg, Germany (Buyer) and Biofrontera AG Hemmelrather Weg 201, 51377 Leverkusen, Germany (Sellers Guarantor) and Discovery Partners International AG Gewerbestrasse 16 CH-4123 Allschwil, Switzerland (Buyers Guarantor) (August 7th, 2006)

Biofrontera Discovery GmbH, having its registered office at Waldhofer Str. 104, D-69127 Heidelberg, registered with the commercial register of the local court of Heidelberg under docket number HRB 7510 (Seller) and Discovery Partners International GmbH, having its registered office at Freiburg, registered with the commercial register of the local court of Freiburg under docket number HRB 7508 (Buyer).

Molecular Imaging Corp – Business Transfer Agreement (April 7th, 2006)

This BUSINESS TRANSFER AGREEMENT (this Agreement) is made and entered into on February 28, 2006 by and among MOLECULAR IMAGING CORPORATION, a Delaware corporation (MIC), MOLECULAR IMAGING CYCLOTRON LLC, a Delaware limited liability company (MIC LLC and, with MIC collectively, the MIC Parties), and P.E.T.NET PHARMACEUTICALS, INC., a Tennessee corporation doing business as PETNET SOLUTIONS (PETNET).

Business Transfer Agreement (March 31st, 2005)

THIS BUSINESS TRANSFER AGREEMENT (this Agreement), made and entered into as of August [dd], 2004, by and between Toyo Ink Mfg. Co., Ltd. (Toyo), a company incorporated under the laws of Japan and having its principal office at 3-13, Kyobashi 2-chome, Chuo-ku, Tokyo, 104-8377 Japan, and Top Image Systems, Ltd. (TIS), a company incorporated under the laws of Israel and having its principal office at 2 Habarzel St. Ramat-Hahayal, Tel-Aviv, 69710 Israel.

Business Transfer Agreement (March 31st, 2005)

THIS BUSINESS TRANSFER AGREEMENT (this Agreement), made and entered into as of August [dd], 2004, by and between Toyo Ink Mfg. Co., Ltd. (Toyo), a company incorporated under the laws of Japan and having its principal office at 3-13, Kyobashi 2-chome, Chuo-ku, Tokyo, 104-8377 Japan, and Top Image Systems, Ltd. (TIS), a company incorporated under the laws of Israel and having its principal office at 2 Habarzel St. Ramat-Hahayal, Tel-Aviv, 69710 Israel.

Business Transfer Agreement (July 16th, 2004)
BUSINESS TRANSFER AGREEMENT Between VIE PLUS S.A. And FINANCIAL NEW LIFE COMPANY LIMITED Dated (April 19th, 2004)

VIE PLUS S.A., a French societe anonyme with a capital of 11,500,000 Euros, with its registered office at Tour Franklin, Terrasse Boieldieu, Puteaux (92800), registered under no. 334 502 788 with the Nanterre Registry of Commerce and Companies, represented by [ ], duly authorized for the purposes of this agreement,

Daka International Inc – Business Transfer Agreement (February 23rd, 1995)